Want to join the conversation?
$TMO 1Q15 10-Q: Revenue: Life Sciences Solutions grew to $1.02Bil vs. 1Q14’s $836MM; Analytical Instruments $727MM vs. 1Q14’s $770MM; Specialty Diagnostics $785MM vs. 1Q14’s $814MM & Laboratory $1.51Bil vs. 1Q14’s $1.59Bil. Operating margin: Life Sciences Solutions 29.3%; Analytical Instruments16.7%; Specialty Diagnostics 27.3% & Laboratory 14.7%.
Apple ($AAPL) reported decline in sales and profits from comparable quarter last year, attributing the decline to announcement of iPhone 7/7s. Sales and profit are being guided higher for next quarter. Apple is a solid company and will continue to dominate tech and consumer electronics segment for a while. Personally, looks like there is little downside in this investment.
Waiting with fingers crossed for $AAPL’s fourth quarter earnings.
Looking ahead to $AAPL earnings release later in the afternoon today? Gene Munster, analyst from Piper Jaffrey and the most respected authority for Apple, had this to say - "The second and slightly larger group of investors believe the tail of the iPhone 7 is irrelevant, and is betting that the iPhone 10th Anniversary will yield a jump in growth from flat to up ~15%."